亚太地区活检设备市场预测至 2027 年 - COVID-19 影响和区域分析(按产品(针式活检、定位线、手术托盘等)、技术(CT 扫描、超声引导活检、立体定向活检、MRI) -引导活检等)、应用(肺活检、肾活检、肝活检、乳腺活检等)和国家/地区

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027


No. of Pages: 142    |    Report Code: TIPRE00012226    |    Category: Life Sciences

Asia Pacific Biopsy Devices Market

市场介绍

活检是由外科医生或放射科医生进行的医学检查,用于评估和消除癌组织。采集组织样本来诊断疾病,尤其是当患者被推测患有癌症时。用于癌症诊断的不同类型的活检包括皮肤活检、真空活检、细针抽吸、刮取活检、切开和切除活检、针吸活检等。

市场概况和动态

亚太地区活检设备市场将从2019年的4.408亿美元增至2027年的7.448亿美元;预计 2019 年至 2027 年复合年增长率为 6.9%。癌症患病率激增以及政府举措不断增多等因素预计将在未来几年推动活检设备市场的增长。然而,市场可能会受到风险因素的影响,例如在预测期内与活检设备相关的限制。

关键细分市场

< /span>

从产品来看,2019年亚太地区活检设备市场中,针式活检细分市场占据最大份额。乳腺活检细分市场占据最大份额, 2019 年的应用。就最终用户而言,超声引导活检细分市场在 2019 年占据了最大的市场份额。

主要来源和上市公司

与亚太地区活检设备市场报告相关的几个主要一手和二手来源是世界卫生组织组织(WHO)、国家生物技术信息中心(NCBI)、Globocan 报告等。

购买理由报告

  • 它提供了对亚太地区活检设备市场格局的了解,并确定了最重要的活检设备细分市场可能会保证丰厚的回报。
  • 它通过了解亚太活检设备市场不断变化的竞争格局来指导保持领先地位。
  • 它通过识别最有可能销售前景的细分市场,帮助有效规划活检设备市场的并购和合作伙伴关系
  • 它促进知识型业务通过对亚太地区活检设备市场各个细分市场的活检设备市场表现进行敏锐和全面的分析来做出决策。
  • 它提供了基于各个细分市场的活检设备市场收入预测。 2019年至2027年期间。

亚太地区生物制药设备市场细分

< strong>按产品

  • 针式活检
    • 核心活检设备< /li>
    • 抽吸活检针
    • 真空辅助活检 (VAB) 设备
  • 定位线
  • 程序托盘
  • 其他

按应用

  • 肺活检
  • 肾脏活检
  • 肝脏活检
  • 乳房活检
  • 其他 span>

通过

技术

  • CT -扫描
  • 超声引导活检
  • 立体定向活检
  • < span>MRI引导活检
  • 其他

按国家/地区

  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳大利亚

公司简介

  • B. Braun Melsungen AG
  • 美敦力
  • 富士胶片公司
  • 丹纳赫
  • 丹纳赫 span>
  • Hologic 公司


Asia Pacific Biopsy Devices Strategic Insights

Strategic insights for Asia Pacific Biopsy Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-biopsy-devices-market-strategic-framework.webp
Get more information on this report

Asia Pacific Biopsy Devices Report Scope

Report Attribute Details
Market size in 2019 US$ 440.80 Million
Market Size by 2027 US$ 744.80 Million
Global CAGR (2019 - 2027) 6.9%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By 产品
  • 针刺活检
  • 定位导线
  • 手术托盘
By 技术
  • CT 扫描
  • 超声引导活检
  • 立体定向引导活检
  • MRI 引导活检
By 应用
  • 肺活检
  • 肾活检
  • 肝活检
  • 乳腺活检
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • B. Braun Melsungen AG
  • Medtronic
  • Fujifilm Corporation
  • Danaher
  • Hologic, Inc.
  • Get more information on this report

    Asia Pacific Biopsy Devices Regional Insights

    The regional scope of Asia Pacific Biopsy Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-biopsy-devices-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Biopsy Devices Market

    The List of Companies - Asia Pacific Biopsy Devices Market

    1. B. Braun Melsungen AG
    2. Medtronic
    3. Fujifilm Corporation
    4. Danaher
    5. Hologic, Inc.

     

    Frequently Asked Questions
    How big is the Asia Pacific Biopsy Devices Market?

    The Asia Pacific Biopsy Devices Market is valued at US$ 440.80 Million in 2019, it is projected to reach US$ 744.80 Million by 2027.

    What is the CAGR for Asia Pacific Biopsy Devices Market by (2019 - 2027)?

    As per our report Asia Pacific Biopsy Devices Market, the market size is valued at US$ 440.80 Million in 2019, projecting it to reach US$ 744.80 Million by 2027. This translates to a CAGR of approximately 6.9% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Biopsy Devices Market report typically cover these key segments-

  • 产品 (针刺活检, 定位导线, 手术托盘)
  • 技术 (CT 扫描, 超声引导活检, 立体定向引导活检, MRI 引导活检)
  • 应用 (肺活检, 肾活检, 肝活检, 乳腺活检)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Biopsy Devices Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Biopsy Devices Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in Asia Pacific Biopsy Devices Market?

    The Asia Pacific Biopsy Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • B. Braun Melsungen AG
  • Medtronic
  • Fujifilm Corporation
  • Danaher
  • Hologic, Inc.
  • Who should buy this report?

    The Asia Pacific Biopsy Devices Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Biopsy Devices Market value chain can benefit from the information contained in a comprehensive market report.